Cargando…

Intravascular lymphoma with hypopituitarism: A case report

BACKGROUND: Intravascular lymphoma (IVL) is a rare subtype of lymphoma involving the growth of lymphoma cells within the vessel lumina without lymphadenopathy. Because of various modes of presentation and its rarity, IVL is often diagnosed postmortem. Herein, we report a case of intravascular B-cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawahigashi, Teiko, Teshima, Shinichi, Tanaka, Eri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443836/
https://www.ncbi.nlm.nih.gov/pubmed/32879852
http://dx.doi.org/10.5306/wjco.v11.i8.673
_version_ 1783573702784319488
author Kawahigashi, Teiko
Teshima, Shinichi
Tanaka, Eri
author_facet Kawahigashi, Teiko
Teshima, Shinichi
Tanaka, Eri
author_sort Kawahigashi, Teiko
collection PubMed
description BACKGROUND: Intravascular lymphoma (IVL) is a rare subtype of lymphoma involving the growth of lymphoma cells within the vessel lumina without lymphadenopathy. Because of various modes of presentation and its rarity, IVL is often diagnosed postmortem. Herein, we report a case of intravascular B-cell lymphoma with hypopituitarism, an extremely rare complication, that was successfully treated with chemotherapy. CASE SUMMARY: An 80-year-old Japanese woman presented with a 7-mo history of a tingling sensation in the lower limbs. She also presented with various other symptoms such as pancytopenia, high fever daily, and unconsciousness with hypoglycemia. Although the doctor who previously treated her diagnosed hypoglycemia as being due to hypopituitarism, the cause of the other symptoms remained uncertain despite a 7-mo evaluation period. We performed bone marrow aspiration to evaluate pancytopenia and found that she had hemophagocytic lymphohistiocytosis (HLH). On the basis of a random skin biopsy for assessing the cause of HLH, she was diagnosed with intravascular B-cell lymphoma. HLH and hypopituitarism were considered secondary to IVL. All her clinical findings matched the presentations of IVL. She was immediately treated with chemotherapy and achieved complete response. She was relapse free two years after treatment. CONCLUSION: IVL should be included in the differential diagnosis of hypopituitarism, which although life-threatening, is treatable through prompt diagnosis and appropriate chemotherapy.
format Online
Article
Text
id pubmed-7443836
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-74438362020-09-01 Intravascular lymphoma with hypopituitarism: A case report Kawahigashi, Teiko Teshima, Shinichi Tanaka, Eri World J Clin Oncol Case Report BACKGROUND: Intravascular lymphoma (IVL) is a rare subtype of lymphoma involving the growth of lymphoma cells within the vessel lumina without lymphadenopathy. Because of various modes of presentation and its rarity, IVL is often diagnosed postmortem. Herein, we report a case of intravascular B-cell lymphoma with hypopituitarism, an extremely rare complication, that was successfully treated with chemotherapy. CASE SUMMARY: An 80-year-old Japanese woman presented with a 7-mo history of a tingling sensation in the lower limbs. She also presented with various other symptoms such as pancytopenia, high fever daily, and unconsciousness with hypoglycemia. Although the doctor who previously treated her diagnosed hypoglycemia as being due to hypopituitarism, the cause of the other symptoms remained uncertain despite a 7-mo evaluation period. We performed bone marrow aspiration to evaluate pancytopenia and found that she had hemophagocytic lymphohistiocytosis (HLH). On the basis of a random skin biopsy for assessing the cause of HLH, she was diagnosed with intravascular B-cell lymphoma. HLH and hypopituitarism were considered secondary to IVL. All her clinical findings matched the presentations of IVL. She was immediately treated with chemotherapy and achieved complete response. She was relapse free two years after treatment. CONCLUSION: IVL should be included in the differential diagnosis of hypopituitarism, which although life-threatening, is treatable through prompt diagnosis and appropriate chemotherapy. Baishideng Publishing Group Inc 2020-08-24 2020-08-24 /pmc/articles/PMC7443836/ /pubmed/32879852 http://dx.doi.org/10.5306/wjco.v11.i8.673 Text en ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Case Report
Kawahigashi, Teiko
Teshima, Shinichi
Tanaka, Eri
Intravascular lymphoma with hypopituitarism: A case report
title Intravascular lymphoma with hypopituitarism: A case report
title_full Intravascular lymphoma with hypopituitarism: A case report
title_fullStr Intravascular lymphoma with hypopituitarism: A case report
title_full_unstemmed Intravascular lymphoma with hypopituitarism: A case report
title_short Intravascular lymphoma with hypopituitarism: A case report
title_sort intravascular lymphoma with hypopituitarism: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443836/
https://www.ncbi.nlm.nih.gov/pubmed/32879852
http://dx.doi.org/10.5306/wjco.v11.i8.673
work_keys_str_mv AT kawahigashiteiko intravascularlymphomawithhypopituitarismacasereport
AT teshimashinichi intravascularlymphomawithhypopituitarismacasereport
AT tanakaeri intravascularlymphomawithhypopituitarismacasereport